P

Phreesia

Automates patient intake for medical practices

Overview

Phreesia provides a cloud-based patient intake platform for medical practices. It automates front-office tasks such as appointment scheduling, insurance verification, and payment processing, helping providers reduce paperwork and spend more time with patients. The platform also supports real-time patient surveys, clinical and behavioral health screenings, and data analytics. It integrates with leading EMR and Practice Management systems so patient data stays up to date across systems. Phreesia runs on a SaaS model with subscription fees, optional premium features, and transaction-based payment processing fees, plus charges for value-added services. Compared with competitors, it emphasizes seamless EMR/PM integration, automated end-to-end intake, and actionable insights from analytics to boost patient engagement and operational efficiency. The goal is to streamline administrative workflows, shorten wait times, and improve the overall patient experience in healthcare settings.

Work here?Claim your company

About Phreesia

Simplify's Rating
Why Phreesia is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & AnalyticsEnterprise SoftwareHealthcare

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wilmington, DE

Founded

2005

Get referred to Phreesia

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • September 2, 2026 revenue rose 10% to $129.5 million, with positive net income.
  • September 14, 2026 DeepIntent partnership widens distribution for ProviderConnect audiences immediately.
  • July 23, 2026 March of Dimes deal and AccessOne drove new product momentum.

What critics are saying

  • July 2026 securities lawsuit targets Phreesia's 2027 guidance and marketing disclosures.
  • May 7, 2026 restructuring cut 220 roles, signaling strained cost discipline and execution pressure.
  • Legacy payment-processing revenue stayed seasonal; if adoption stalls, growth depends on fragile acquisition bets.

What makes Phreesia unique

  • Phreesia touches one in six U.S. patient visits, creating unmatched workflow reach.
  • AccessOne expands Phreesia into patient financing, not just intake software.
  • ProviderConnect links patient and clinician audiences before appointments, a rare healthcare media network.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$461.9M

Above

Industry Average

Funded Over

10 Rounds

Post IPO Debt funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Debt Funding Comparison Coming Soon

Benefits

  • Remote Work Options
  • Home Office Stipend
  • Phone/Internet Stipend
  • Wellness Program
  • Flexible Work Hours
  • Paid Holidays
  • Paid Vacation
  • Parental Leave
  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance

Stock Price

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

0%
Market Wire News
Nov 3rd, 2026
Phreesia's Sophia Wagner named to Becker's 2026 list of Health IT & Revenue Cycle Up-and-Comers.

Phreesia's Sophia Wagner named to Becker's 2026 list of Health IT & Revenue Cycle Up-and-Comers. MWN-AI** Summary. Phreesia, a prominent player in patient intake and engagement, proudly announces that Sophia Wagner, its Vice President of Product Engineering, has been recognized on Becker's Hospital Review's 2026 list of Health IT & Revenue Cycle Up-and-Comers. This accolade honors innovative leaders within hospitals, health systems, and healthcare companies who are driving technological advancements, enhancing financial performance, and fueling organizational growth. In her pivotal role at Phreesia, Wagner oversees various teams focused on product management, engineering, and operations, particularly within the realms of payments and provider financing. She manages an impressive portfolio that encompasses payment facilitation, processing, and patient billing - overseeing nearly $5 billion in annual payment processing volume. Her leadership has been instrumental following Phreesia's acquisition of AccessOne, fostering the ongoing development of provider financing capabilities. Colleagues commend Wagner's unique ability to couple critical thinking with a deep understanding of the revenue cycle market. Kristin Roberts, Senior Vice President of Product at Phreesia, emphasized her talent for transforming opportunities into substantial benefits for both the company and its clients. Wagner has a strong track record at Phreesia, having previously led initiatives that saw payment processing volumes soar from $2.8 billion to nearly $4 billion within two years. She was also pivotal in launching a new market segment prior to the company's initial public offering and played a crucial role in the due diligence process for a $38 million acquisition. Expressing her gratitude for the recognition, Wagner emphasized her commitment to collaboration and innovation, ultimately aiming to ease the financial complexities of healthcare for patients and organizations alike. Phreesia continues to empower stakeholders by providing digital solutions that enhance patient engagement and improve healthcare outcomes. For more information, please visit www.phreesia.com. MWN-AI** Analysis. Sophia Wagner's recognition as one of the Up-and-Comers in Health IT & Revenue Cycle by Becker's Hospital Review adds a noteworthy perspective on Phreesia's future prospects in the healthcare technology market. As the Vice President of Product Engineering, her strategic leadership has played a pivotal role in scaling the company's payment processing from $2.8 billion to nearly $4 billion in just two years. This trajectory indicates significant momentum that could bolster Phreesia's competitive edge in the evolving healthcare landscape. Investors should consider the implications of this recognition seriously. Wagner's expertise in product vision and operational execution will likely streamline the integration of Phreesia's payment facilitation and provider financing solutions, particularly following the AccessOne acquisition. Given the healthcare industry's increasing focus on seamless financial processes and patient engagement, Phreesia is strategically positioned to capitalize on this trend. Moreover, Wagner's history of directing growth strategies suggests that Phreesia could continue to experience robust financial performance, enhancing shareholder value. The company's ability to facilitate approximately 180 million patient visits in 2025 showcases its expansive market reach, which could translate into sustained revenue growth. With the ongoing transition in healthcare towards digital solutions, Phreesia's commitment to improving both patient and provider experiences makes it an attractive candidate for investment. If Wagner continues to leverage her skills effectively, Phreesia will likely remain a leader in the healthcare tech space. Investors may want to keep a close eye on her future initiatives and the company's response to shifting market demands. Overall, Phreesia's combination of leadership talent and innovative product development positions it favorably for continued advancement in the sector. **MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release. November 03, 2026 04:13:00 pm Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Sophia Wagner, Vice President of Product Engineering, has been named to Becker's Hospital Review 's 2026 list of Health IT & Revenue Cycle Up-and-Comers. The list recognizes emerging leaders at hospitals, health systems and healthcare companies who are advancing technology, improving financial performance and guiding organizational growth. Becker's developed the list through nominations and editorial research. In her current role, Sophia leads teams across product management, engineering and operations, supporting Phreesia's payments and provider financing businesses. She sets product vision and guides execution for a portfolio that includes payment facilitation and processing, financing, patient payments, and patient billing and statements. Her responsibilities include oversight of nearly $5 billion in annual payment processing volume and continued development of provider financing capabilities following Phreesia's acquisition of AccessOne. "Sophia is one of the sharpest, most resilient leaders I know," said Kristin Roberts, Senior Vice President of Product at Phreesia. "She combines rigorous critical thinking with a deep command of the revenue cycle market and has a rare ability to turn opportunity into meaningful impact for both Phreesia and our clients." In previous roles at Phreesia, Sophia directed growth and retention strategy as payment processing volume increased from $2.8 billion to nearly $4 billion over two years. She also launched a new market segment ahead of the company's initial public offering and managed due diligence for a $38 million acquisition. "Being recognized by Becker's is an honor," said Sophia Wagner, Vice President of Product Engineering at Phreesia. "The most rewarding part of my work is bringing teams together to turn a product vision into something that helps patients and healthcare organizations. I'm grateful to work with colleagues who care deeply about the details and share a commitment to making the financial side of healthcare easier." About Phreesia Phreesia is the trusted leader in patient activation, giving healthcare providers, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled approximately 180 million patient visits in 2025 - 1 in 6 visits across the U.S. - scale that Market Wire News believe allows Market Wire News to make meaningful impact. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives efficiency and improves healthcare outcomes. To learn more, visit phreesia.com. FAQ**. How does Sophia Wagner's leadership as Vice President of Product Engineering at Phreesia Inc. PHR contribute to the company's growth in payment processing volume? Sophia Wagner's strategic focus on innovation and efficiency in product engineering at Phreesia Inc. enhances payment processing capabilities, driving increased transaction volumes and contributing significantly to the company's growth. What specific strategies has Sophia Wagner implemented to enhance Phreesia Inc. PHR's capabilities in provider financing since the acquisition of AccessOne? As of 2026, Sophia Wagner has focused on integrating AccessOne's financial technology into Phreesia's platform, enhancing seamless payment solutions, and expanding provider partnerships to improve financing options and patient access. In what ways does Phreesia Inc. PHR plan to leverage Sophia Wagner's recognition as a Health IT & Revenue Cycle Up-and-Comer to strengthen its market position? Phreesia Inc. plans to leverage Sophia Wagner's recognition by enhancing its brand visibility, attracting new clients, and solidifying partnerships within the healthcare sector, ultimately aiming to drive innovation and improve its market position in Health IT and revenue cycle management. How does Phreesia Inc. PHR ensure that its digital solutions align with Sophia Wagner's vision for improving the patient experience and healthcare outcomes? Phreesia Inc. aligns its digital solutions with Sophia Wagner's vision by leveraging data analytics and patient feedback to enhance user experience and streamline healthcare processes, ultimately improving patient outcomes and satisfaction. **MWN-AI FAQ is based on asking OpenAI questions about Phreesia Inc. (NYSE: PHR).

MyChesCo
Oct 18th, 2026
Phreesia executive earns recognition for healthcare leadership.

Phreesia executive earns recognition for healthcare leadership. WILMINGTON, DE - Phreesia executive Michael Rasbury has been named to Becker's Hospital Review's 2026 list of Rising Stars: Healthcare Leaders Under 40, recognizing his work overseeing patient financing operations and improving service delivery for healthcare organizations. Rasbury serves as vice president of AccessOne Solutions at Phreesia, where he manages approximately 80 employees supporting healthcare providers with patient payment arrangements, collections and cash flow management. His responsibilities include patient financial engagement, client implementation and operational performance as healthcare organizations seek to improve payment processes while offering patients flexible options for managing medical expenses. Discover more Local advertising services Community news subscription Local news updates Becker's Hospital Review selected its 2026 honorees through nominations and editorial research. The annual recognition identifies healthcare professionals younger than 40 who have demonstrated leadership in addressing industry challenges. Rasbury has worked at Phreesia for more than a decade, advancing from project manager to vice president. Before assuming leadership of AccessOne, he directed Phreesia's client services organization and managed consultants across the United States, Canada and India. During that period, he oversaw initiatives to improve implementation efficiency, reduce the time required to launch client projects and standardize onboarding procedures. Those efforts also focused on strengthening relationships with healthcare organizations and improving consistency during the implementation of Phreesia's services. "What motivates me is building teams and processes that help our clients succeed and make the financial side of healthcare easier for patients," Rasbury said. Phreesia provides technology for patient intake, outreach and engagement, while its AccessOne business focuses on patient financial services and payment management. Rasbury's recognition comes as he leads AccessOne's operational teams and efforts to improve the delivery of financial services to healthcare providers and their patients. Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources - free for everyone. If you value that, click here to become a patron today. Local advertising services Discover more Online newspaper access Pennsylvania travel guide

Business Insider
Oct 11th, 2026
Barclays reaffirms their Hold rating on Phreesia (PHR).

Barclays reaffirms their Hold rating on Phreesia (PHR). Oct. 11, 2026, 09:15 PM In a report released on October 9, Glen Santangelo from Barclays maintained a Hold rating on Phreesia, with a price target of $11.00. The company's shares closed last Friday at $10.81. According to TipRanks, Santangelo is a 4-star analyst with an average return of 3.8% and a 52.15% success rate. Santangelo covers the Healthcare sector, focusing on stocks such as Hims & Hers Health, Align Tech, and Cencora. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Phreesia with a $13.22 average price target. Based on Phreesia's latest earnings release for the quarter ending July 31, the company reported a quarterly revenue of $129.46 million and a net profit of $1.92 million. In comparison, last year the company earned a revenue of $117.26 million and had a net profit of $654 thousand Read More on PHR:

Phreesia
Sep 25th, 2026
Phreesia named one of TIME's World's Top HealthTech Companies 2026.

Phreesia named one of TIME's World's Top HealthTech Companies 2026. * Published - September 25, 2026 Making care easier - in its clients' words. More than 4,700 healthcare organizations use Phreesia to make care easier for patients, practices and staff. Here's what that looks like every day. "The patient impact is undeniable." Cassandra englund-thompson, strategic project consultant, summit orthopedics. Appointment Accelerator(R) offers canceled appointments to eligible patients automatically - helping people get care sooner while keeping schedules full, without adding work for staff. "Registration is revenue." Matthew moore, chief technology innovation officer, effingham health system. Accurate registration supports cleaner claims. Upfront eligibility checks catch issues earlier. And clear, convenient payment options help patients resolve balances sooner. "Payments, scheduling and refills are exactly where AI helps." Sneha Patel, CEO, COO, MPAS, PA-C, metroplex medical centres. "Instead of hiring more FTEs to do manual tasks, we're using technology to solve problems at scale," Patel said. "Phreesia was a strong partner for us from the beginning." Troy moore, CEO, Ellinwood hospital & clinic. Technology creates more value when it becomes a chance to improve how the organization operates. For Ellinwood, that meant involving the right people, looking beyond any one workflow and staying open to change. Making care easier every day. Today, Phreesia supports more than 180 million patient visits each year - about 1 in 6 visits across the U.S. Across its network, 85% of patients check themselves in, saving staff more than five minutes per self-service check-in. And 97% of patients report being satisfied with their Phreesia experience. For more than 20 years, Phreesia has focused on technology patients use, teams value and practices can build on. Phreesia is honored to be named one of TIME's World's Top HealthTech Companies 2026 - and excited to keep making care easier every day, for everyone. G2 Leader Capterra Shortlist KLAS Best in KLAS HITRUST CRF SOC 2 TYPE 2 The best-performing practices run on Phreesia. See what changes when your platform closes the loop - from first call to final payment.

MarketBeat
Sep 22nd, 2026
Insider selling: Phreesia (NYSE:PHR) General Counsel sells $67,152.96 in stock.

Insider selling: Phreesia (NYSE:PHR) General Counsel sells $67,152.96 in stock. September 22, 2026 Key points. * Phreesia General Counsel Allison Hoffman sold 6,662 shares at an average price of $10.08, generating $67,152.96. The Rule 10b5-1 sale covered tax withholding tied to vested equity awards and reduced her ownership by 2.44%. * Phreesia shares rose 0.7% to $10.11, giving the company a market capitalization of approximately $627 million. The stock remains well below its 52-week high of $25.00. * The company's latest quarterly revenue increased 10.4% year over year to $129.46 million, but earnings of $0.03 per share missed analyst expectations of $0.09. Analysts maintain a consensus Hold rating with a $14.00 price target. * Five stocks we like better than Phreesia. Phreesia, Inc. (NYSE:PHR - Get Free Report) General Counsel Allison Hoffman sold 6,662 shares of the company's stock in a transaction on Monday, September 21st. The stock was sold at an average price of $10.08, for a total transaction of $67,152.96. Following the completion of the transaction, the general counsel directly owned 266,574 shares in the company, valued at $2,687,065.92. This trade represents a 2.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Phreesia stock up 0.7%. Shares of NYSE:PHR traded up $0.07 during midday trading on Tuesday, hitting $10.11. 476,751 shares of the stock were exchanged, compared to its average volume of 1,449,417. The company has a market capitalization of $627.22 million, a PE ratio of 59.44 and a beta of 0.86. Phreesia, Inc. has a 52-week low of $7.77 and a 52-week high of $25.00. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.76 and a current ratio of 1.76. The business's fifty day simple moving average is $11.15 and its two-hundred day simple moving average is $10.32. Phreesia (NYSE:PHR - Get Free Report) last issued its earnings results on Wednesday, September 2nd. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.06). Phreesia had a return on equity of 5.22% and a net margin of 2.06%.The firm had revenue of $129.46 million during the quarter, compared to analyst estimates of $129.06 million. During the same period in the previous year, the company earned $0.01 earnings per share. The business's revenue for the quarter was up 10.4% on a year-over-year basis. As a group, research analysts predict that Phreesia, Inc. will post 0.33 earnings per share for the current fiscal year. Wall Street analyst weigh in. PHR has been the topic of several recent research reports. Robert W. Baird raised their price objective on shares of Phreesia from $10.00 to $11.00 and gave the company a "neutral" rating in a research report on Friday, September 4th. Weiss Ratings cut shares of Phreesia from a "sell (d+)" rating to a "sell (d)" rating in a report on Friday, September 4th. Truist Financial increased their target price on shares of Phreesia from $11.00 to $12.00 and gave the stock a "hold" rating in a research report on Thursday, May 28th. Needham & Company LLC reaffirmed a "buy" rating and issued a $14.00 price target on shares of Phreesia in a research report on Monday, August 31st. Finally, Royal Bank Of Canada reiterated an "outperform" rating and set a $19.00 price target on shares of Phreesia in a research note on Thursday, September 3rd. Eight equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $14.00. Discover more Portfolio Management Tools Research tools access Institutional investors weigh in on Phreesia. Several hedge funds have recently modified their holdings of the business. EverSource Wealth Advisors LLC increased its position in Phreesia by 1,119.8% during the first quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company's stock worth $27,000 after acquiring an additional 3,001 shares during the period. New York State Teachers Retirement System bought a new stake in Phreesia in the 1st quarter valued at $44,000. Rockefeller Capital Management L.P. boosted its holdings in Phreesia by 354.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company's stock valued at $47,000 after purchasing an additional 2,149 shares during the period. Allworth Financial LP acquired a new stake in Phreesia in the 2nd quarter worth $58,000. Finally, Essential Partners LLC grew its position in Phreesia by 2,016.6% in the 1st quarter. Essential Partners LLC now owns 9,313 shares of the company's stock worth $78,000 after purchasing an additional 8,873 shares during the last quarter. 92.10% of the stock is owned by institutional investors. Phreesia company profile. Phreesia, Inc is a healthcare technology company that provides software and services designed to help healthcare organizations manage patient intake and engagement. Its platform digitizes administrative and clinical processes that traditionally rely on paper forms, manual data entry, and separate payment systems. The company's offerings include digital patient check-in and registration, insurance and demographic information collection, appointment-related communications, electronic forms and consent management, patient surveys, and payment processing. Further reading. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Phreesia, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phreesia wasn't on the list. While Phreesia currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely. Continue following MarketBeat

Recently Posted Jobs

Sign up to get curated job recommendations

Phreesia is Hiring for 8 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs